As indicated in Exhibit 1, the differences between the Alternative and Base Estimates are found in the estimation of the impact of fine particle reductions on premature mortality and the valuation of reducing the risk of premature mortality and the risk of chronic bronchitis.
The estimate is of the impact of the particle reductions.